{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "DOCU",
  "name": "DocuSign, Inc.",
  "url": "https://orbyd.app/dossiers/DOCU/",
  "json_url": "https://orbyd.app/dossiers/DOCU.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Legacy e-signature base being re-wrapped as AI \"Intelligent Agreement Management\" — IAM went 10.8%→12.6% of ARR in one quarter and is guided to ~18% by 2027-01-31, but total growth is still ~9%. Price has recovered to roughly the consensus target with the ~2026-09-03 Q2 print unresolved.",
  "invalidation_trigger": "A weekly close below $54 returns price inside the $50–$54 band where post-Q1 sell-side targets were reset on 2026-06-05 and gives back the summer advance; secondarily, a Q2 FY27 print (~2026-09-03) that leaves IAM materially short of the ~18%-of-ARR full-year path.",
  "catalyst_date": "2026-09-03",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "ai-enterprise-software",
    "physical-ai-robotics",
    "oil-energy-geopolitical"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Fiscal year ends January 31 — 'fiscal 2027' is the year ending 2027-01-31, so quarter labels run about eleven months ahead of the calendar.",
    "Large GAAP/non-GAAP gap from stock-based compensation: Q1 FY27 GAAP net income $78.2M versus non-GAAP $214.9M. Multiples differ sharply by which line is used.",
    "IAM percentage-of-ARR is a company-defined metric with no audited cross-vendor comparable; it is disclosed quarterly and is the primary way management frames the pivot.",
    "Results are released after the US close, historically on the first Thursday of March, June, September and December, with the date confirmed roughly two weeks prior."
  ],
  "body_markdown": "## Current Thesis\nThe leg on offer is a legacy-pivot re-rate: a mature e-signature franchise growing high single digits is being repriced on the mix shift into Intelligent Agreement Management (IAM), the company's AI-native agreement layer. IAM was 12.6% of total ARR at 2026-04-30 against 10.8% at 2026-01-31, with management guiding to roughly 18% of ARR and over $600M of IAM ARR by fiscal year-end (2027-01-31). Everything else — 30%+ operating margins, near-$300M quarterly free cash flow, a buyback running above free cash flow — is the funding mechanism, not the story. At $60.26 (2026-08-07 close) the stock has recovered 25.8% over three months while sitting 29.1% below the 52-week high of $85.01, and it now trades at or above where most of the sell-side reset targets the day after the Q1 print.\n\n## Bull Case\n- IAM mix moved 180bp in a single quarter — 10.8% of ARR at 2026-01-31 to 12.6% at 2026-04-30 — with ~40,000 customers described as investing in the platform (Q1 FY27 release, 2026-06-04).\n- Margin structure is doing real work: non-GAAP operating margin 32.0% in Q1 FY27, and the FY27 full-year non-GAAP operating margin guide was raised to 30.5–31.0%.\n- Cash generation is not in dispute: operating cash flow $321.7M and free cash flow $289.4M in Q1 FY27, against $1.0B of cash and investments.\n- Repurchases of $317.5M in Q1 FY27 exceeded free cash flow for the quarter — the company was the marginal buyer of its own stock through the drawdown.\n- GAAP profitable, not just adjusted: GAAP net income $78.2M and GAAP diluted EPS $0.40 in Q1 FY27.\n- Two of the three dated post-print revisions went up: Jefferies $45→$50 and Citi $50→$54, both 2026-06-05.\n\n## Bear Case\n- The pivot has not yet moved the top line. Q1 FY27 revenue was $830.2M, +9% YoY, and that included roughly 1.6 percentage points of FX benefit. FY27 revenue is guided to $3.490–3.502B, +9% at the midpoint, with ARR growth of 8.25–8.75%.\n- Q2 FY27 is guided to $865–869M, about +8% YoY at the midpoint — a step down from the +9% just printed — with non-GAAP operating margin of 29.7–30.2%, below the 32.0% Q1 level.\n- Even at the ~18% FY-end IAM target, more than four-fifths of ARR remains the older seat-and-envelope base.\n- The market's reaction to a beat was negative: Zacks flagged a 7.2% decline in the sessions following the 2026-06-04 Q1 report.\n- Wedbush cut its target from $75 to $58 on 2026-06-05 and stayed at Hold — the sharpest single dated revision in the set.\n- The competitive overhang is being funded in public: The Information reported on 2026-08-07 that legal-AI vendor Harvey was in talks to raise at a $15.5B valuation, which is the same \"agents absorb contract workflow\" thesis expressed as a private-market bid.\n\n## Setup & Price Structure\nClose $60.26 on 2026-08-07; 52-week high $85.01; 29.1% below that high; three-month return +25.8%; RSI(14) 64.5. The structure is a recovery leg off a deep reset, not a breakout to new highs — the stock has retraced roughly a third of the distance back toward the prior high and stalled into the zone where the sell-side re-anchored. Aggregated sell-side data retrieved 2026-08-08 showed a Hold consensus with an average target of $59.88 across 22 analysts, i.e. price has caught the average target. The three dated 2026-06-05 revisions ($50 Jefferies, $54 Citi, $58 Wedbush) all sit below the last close. RSI in the mid-60s is elevated without being stretched.\n\nLife-cycle: **MATURING**. IAM has been the disclosed centerpiece metric through multiple reporting cycles and was quantified again on 2026-06-04; the most recent dated analyst revisions are 2026-06-05, with nothing since; the trailing 30-day news feed carries no company-specific DOCU headline at all. The narrative is well understood and still working operationally, with moderating attention — that is the definition the site uses for MATURING rather than ACCELERATING.\n\nCrowding and positioning observables, stated as observables: price at/above the aggregate consensus target and above all three post-print firm targets; RSI 64.5 after a 25.8% three-month advance; an unreported quarter (ended 2026-07-31) with a print roughly four weeks out; company repurchases of $317.5M in the most recent reported quarter running ahead of $289.4M free cash flow, which is both a support and an offset to heavy stock-based compensation (GAAP net income $78.2M vs non-GAAP $214.9M in Q1 FY27). No insider transaction filings appear in the current window.\n\n## Catalyst Calendar (next 30 days)\n- **~2026-08-20 (est.)** — Announcement of Q2 FY27 earnings call timing. DocuSign has historically confirmed the date roughly two weeks ahead; this fixes the binary.\n- **~2026-09-03 (est.)** — Q2 FY27 results, quarter ended 2026-07-31. Reported after the close, historically the first Thursday of the month. The gradeable items: revenue against the $865–869M guide, non-GAAP operating margin against 29.7–30.2%, IAM as a percentage of total ARR against the ~18% full-year path, and any change to the 8.25–8.75% FY27 ARR growth range.\n\n## What Would Change Our Mind\nThe mix shift is the entire argument, so the first thing that breaks it is an IAM percentage-of-ARR reading at the September print that does not sit on the trajectory toward ~18% by 2027-01-31 — a flat or single-quarter-stalled figure would say the platform is landing but not expanding. The second is the FY27 ARR growth range: any trim below the 8.25% low end would mean the legacy base is decaying faster than IAM adds. On price, a weekly close below $54 puts the stock back inside the $50–$54 band where Jefferies and Citi re-anchored on 2026-06-05 and surrenders the summer recovery leg. Conversely, a Q2 print that raises FY27 ARR growth alongside an IAM figure comfortably above 14% would argue the pivot is compounding rather than substituting, and would justify revisiting the read.\n\n## Correlation Notes\n- Trades with the mid-multiple application-software complex — the cohort that re-rates on rate expectations and on hyperscaler-adjacent AI sentiment rather than on its own bookings.\n- Sits directly in the \"AI agents eat seat-based SaaS\" factor. Bear commentary on that theme was live in the window (Benzinga, 2026-07-02 and 2026-07-07, on Michael Burry's AI short thesis), and the Harvey funding report of 2026-08-07 prices the disruptive side of it.\n- Identity-verification and proof-of-human infrastructure headlines (Benzinga, 2026-07-24, on a $52.5M Pantera/Bain round) touch the same adjacent market DocuSign sells into, though no revenue linkage has been disclosed.\n- FX matters at the margin: roughly 1.6 percentage points of Q1 FY27's 9% growth came from currency, so dollar strength subtracts from reported growth optics independent of demand.",
  "first_seen": "2026-07-30",
  "last_analyzed": "2026-08-08T07:38:52+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}